Alignment Healthcare insider schedules stock sales
Alignment Healthcare, Inc. submitted a Rule 144 notice relating to planned sales of Common Stock by a selling holder under existing 10b5-1 Sales Plan arrangements.
Rhea-AI Filing Summary
Alignment Healthcare, Inc. submitted a Rule 144 notice relating to planned sales of Common Stock by a selling holder under existing 10b5-1 Sales Plan arrangements. The filing lists multiple executed or scheduled dispositions by Dawn Maroney, including sales of 100,000 shares on 01/02/2026 and 228,152 shares on 01/06/2026. Shares outstanding were 204,296,493 as of 03/11/2026.
Positive
- None.
Negative
- None.
Insights
Routine, pre-arranged insider dispositions under a 10b5-1 plan are reported.
The filing lists multiple sales executed or scheduled under a 10b5-1 Sales Plan for Dawn Maroney, with dated entries and share counts such as 100,000 (01/02/2026) and 228,152 (01/06/2026). These entries reflect dispositions rather than grants.
The primary dependency is the existence and terms of the 10b5-1 plan; the filing documents plan-based transactions but does not alter outstanding share count. Subsequent filings or trade reports will show final proceeds and any remaining planned sales.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Alignment Healthcare's (ALHC) Form 144 disclose?
Who is the selling holder named in the ALHC filing?
Are the transactions described as 10b5-1 plan sales?
Can I see examples of transaction sizes in the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.